Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Biodel advances ultra-rapid-acting insulin product BIOD-531 into clinical development

Nov. 11, 2013

Dainippon Sumitomo Pharma prepares new 11-beta-HSD1 inhibitors

Nov. 11, 2013

AEterna Zentaris submits NDA to FDA for macimorelin acetate

Nov. 7, 2013

Noven Pharmaceuticals launches Brisdelle in the U.S.

Nov. 6, 2013

siRNA therapeutics targeted for AIP

Nov. 6, 2013

Korean researchers prepare new DGAT1 inhibitors

Nov. 6, 2013

BioLineRx receives approval to begin trial of BL-7010 in celiac disease

Nov. 5, 2013

Testing supports development of Pluristem's PLX cells for pre-eclampsia

Nov. 5, 2013

Mochida Pharmaceutical synthesizes novel FFA1 agonists

Nov. 5, 2013

Isis Pharmaceuticals begins phase II trial of ISIS-GCCRRx in combination with metformin

Nov. 5, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...